PeptideStack
5.2kquestions
20kanswers
220users

How do I compare FGP and KP on lead time to the Netherlands?

Asked 27 Jun 2025Modified 11 months agoViewed 17k times
23

For reference: FGP · KP · the Netherlands.

Both of these get recommended confidently by different people, which suggests neither is obviously right.

My constraints are cost, measurement resolution and how much handling I am prepared to do — in roughly that order.

Under what conditions does the answer flip?

vendor-comparison
vendor-comparison

Side-by-side comparison of suppliers on measurable axes - independently confirmed purity and content, lead time, cold-chain handling,…

388 questions
international-shipping
international-shipping

Cross-border movement of research material: transit lanes and their thermal profiles, tracked versus untracked, declaration accuracy, and what…

471 questions
cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

578 questions
shareeditfollowflag
SW
askedswab_and_wait13k1627 Jun 2025
6Same question before my first order, and the small-order-then-test route worked. – aine_mulcahy 13 days ago
5Do you have a certificate in front of you, or are you asking before requesting one? – Dr_Rosalind_Achebe 9 months ago
add a comment

5 Answers

Accepted answer first, then by votes
82

Accepted answer

More usefully, this is the question where methodology matters more than the conclusion.

Compare documentation on a fixed checklist rather than by impression: lot specificity, method section, chromatogram availability, quantified content, water and counter-ion figures, and whether the code is on the vial.

Put another way, cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.

Gradient slope, column chemistry and detection wavelength all affect the reported purity figure, which is why the method section is the part that makes results comparable.

Compare content, not purity. Purity clusters and content does not.

shareimprove this answerflag
MO
answered · acceptedmarta_okonkwo190k2584 Aug 2025
8Confirming that a small first order plus one independent submission is the cheapest route. – charge_state_3 22 days ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
73

Answering this needs the axis. A supplier that is best on paperwork and a supplier that is best on price are both correct answers to different questions.

Submitting to different laboratories introduces a method difference that commonly exceeds the supplier difference. Gradient slope alone can move a reported purity figure by a per cent in either direction.

On the detail: lead time and lane behaviour are supplier properties too and are easier to compare than analytical ones, because they need no laboratory at all.

Content assay results across the published datasets vary considerably more between suppliers than purity does, which makes content the more discriminating axis.

Price per milligram of measured peptide, not per milligram of label claim.

shareimprove this answerflag
SD
answeredsunniva_dahl22k2724 Jul 2025
38

The honest answer is that most claimed differences between reputable suppliers are inside inter-laboratory noise.

To compare properly: order the same compound at the same nominal strength from each supplier, submit all samples to the same laboratory in the same submission if possible, and ask for the same test set on each.

Publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Use a fixed documentation checklist rather than an impression.

shareimprove this answerflag
MO
answeredmarta_okonkwo190k25815 Aug 2025
4Any view on whether two lots agreeing is worth more than one lot excelling? I think it is. – sian_llewellyn 20 days ago
3Same experience here, different supplier. – m_haraldsen 9 months ago
add a comment
30

Answer first: comparing suppliers is only meaningful if the comparison holds the laboratory, the method and the compound constant, and most published comparisons hold none of them.

Content is the more discriminating measurement than purity for supplier comparison, because purity clusters tightly among competent suppliers and content does not.

The ratings on this site are a community opinion average on a ten-point scale and are not reconciled with any other community's figures.

The caveat is that a comparison is a snapshot of the lots compared, and lots change.

Name the laboratory and the dates or the comparison cannot be reproduced.

shareimprove this answerflag
TO
answeredt_oyelaran79k4827 Aug 2025
23

A single member running three suppliers on one method is worth more than thirty members running one supplier each.

Sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.

Inter-laboratory spread on identical peptide material is routinely half a per cent to a per cent by RP-HPLC, which is the noise floor for any cross-laboratory comparison.

No supplier on this site pays for its position, and the storefront links are marked nofollow and sponsored.

One laboratory, one method, one submission. Otherwise it is not a comparison.

shareimprove this answerflag
OF
answeredorla_ferriter89k1487 Sept 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.